Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome

BACKGROUND: Genetic screening programs in unselected individuals with increased levels of low-density lipoprotein cholesterol (LDL-C) have shown modest results in identifying individuals with familial hypercholesterolemia (FH). OBJECTIVES: This study assessed the prevalence of genetically confirmed FH in patients with acute coronary syndrome (ACS) and compared the diagnostic performance of FH clinical criteria versus FH genetic testing. METHODS: Genetic study of 7 genes (LDLR, APOB, PCSK9, APOE, STAP1, LDLRAP1, and LIPA) associated with FH and 12 common alleles associated with polygenic hyperc... Mehr ...

Verfasser: Amor-Salamanca, Almudena
Castillo, Sergio
Gonzalez-Vioque, Emiliano
Dominguez, Fernando
Quintana, Lucía
Lluís-Ganella, Carla
Escudier, Juan Manuel
Virues-Ortega, Javier
Lara-Pezzi, Enrique
Alonso-Pulpon, Luis
Garcia-Pavia, Pablo
Dokumenttyp: Artículo
Erscheinungsdatum: 2017
Verlag/Hrsg.: Elsevier
Schlagwörter: Dutch Lipid Clinic / Simon Broome criteria / Cholesterol / Genetics / Low-density lipoprotein cholesterol / Adaptor Proteins / Signal Transducing / Apolipoprotein B-100 / Apolipoproteins E / LDL / Comorbidity / Female / Genetic Testing / Humans / Hypolipidemic Agents / Male / Middle Aged / Multifactorial Inheritance / Patient Selection / Prevalence / Prognosis / Proprotein Convertase 9 / Receptors / Reproducibility of Results / Risk Assessment / Risk Factors / Spain / Sterol Esterase / Acute Coronary Syndrome / Hyperlipoproteinemia Type II
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26634282
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/20.500.12105/7983